Clinical Trial Update: European Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS)

View source ↗

Summary

The European Registry of Anti-Epileptic Drug Use in Lennox-Gastaut Syndrome has completed enrollment and data collection for the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Snippet

Sponsor: Eisai Limited | Conditions: Lennox-Gastaut Syndrome | Status: COMPLETED